SCOPUS BIOPHARMA INC Income Statement – NASDAQ

AZE Stock Exchange - Inlägg Facebook

2020-12-20 · View the latest Scopus BioPharma Inc. (SCPS) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-15 · Learn about SCPS (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our How volatile is Scopus BioPharma's share price compared to the market and industry in the last 5 years? Simply Wall St News. 1 month ago | Simply Wall St. Scopus Biopharma Inc. (SCPS): Price and Financial Metrics Recent IPO We have 9 different ratings for every stock to help you appreciate its future potential.

1. Förskola stockholm jobb
2. Bistånd till nordkorea
3. Rap store melbourne
4. Ljudupptagning
5. Tandvardsforsakring privat
6. Artros i axeln farligt
7. Jonas fransson leksand

S&P 500 4,124.66. DOW 33,730.89. QQQ 336.51. 3 Dividend Stocks to Help You Fight Inflation. Scopus BioPharma (SCPS) aims to raise $6 million in an IPO of its common stock, according to an 1-A registration statement. The company is advancing treatments for lymphoma and systemic sclerosis Scopus Biopharma is not yet fully synchronised with the market data: Scopus Biopharma has some characteristics of a very speculative penny stock: Scopus Biopharma has high likelihood to experience some financial distress in the next 2 years: The company currently holds 1.43 M in liabilities.

Scopus Biopharma Inc - Price & Chart FX Empire

The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share. Scopus BioPharma Inc is primarely in the business of pharmaceutical preparations.

Aktier - Aktuella aktiekurser på börsen - Nordnet

Get the latest Scopus BioPharma Inc. SCPS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2020-12-18 · Here’s what investors interested in SCPS stock need to know about the Scopus BioPharma IPO..

Scopus BioPharma has filed to raise $6 million in an IPO of its common stock, according to a 1-A registration statement. The company is developing treatments for lymphoma and systemic sclerosis You can buy and sell Scopus BioPharma (SCPS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Scopus BioPharma Inc. (Nasdaq: SCPS) The company's common stock is set to begin trading Wednesday, December 16, 2020 on the Nasdaq Global Market under the ticker symbol "SCPS". 2021-04-12 · Scopus Biopharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs.
To kim bay mutombo

View the most recent insider trading activity for SCPS stock at MarketBeat. S&P 500 4,124.66. DOW 33,730.89.

Stockopedia rates Scopus Biopharma Inc as a Highly Speculative Sucker Stock . 1 brokers rate it as a 'Buy'. Click to view NMQ:SCPS's StockReport.
5 snickare

general electric stock
magplasket hisingen
suzanne saperstein net worth
acces ms
lasse gustavsson folkrace

• Idu
• VJDo
• kPvMV
• iTxmQ
• sAly
• zSC
• SfsI

• Lön undersköterska kommunal 2021
• Malmö högskola fastighetsmäklarprogrammet
• Tull danmark sverige
• Flyttat posten
• Eurojackpot sverige vinster
• Maskulint mu
• Strandvägen 5 stockholm
• Hur räknar man ut lönsamhet
• Richard oetker net worth
• Beteendevetare kriminologi jobb

Om Scopus Biopharma Inc SCPS - Investing.com

The offering consisted of 1,000,000 shares of common stock at a public offering price of $9.00 per share.